期刊文献+

胸苷激酶1对恶性肿瘤的早期诊断价值 被引量:1

Assess the earlier diagnostic value of thymidine kinase I on malignant tumors
下载PDF
导出
摘要 目的探讨胸苷激酶1(thymidine kinase1,TK1)在恶性肿瘤早期诊断中的价值。方法选择健康体检组465例、对照组43例、良性增生组39例、恶性肿瘤组37例、癌前病变组34例作为受试对象.采用点印迹免疫酶化学发光法检测TK1水平,采用微粒子发光法检测传统肿瘤标志物CEA、AFP、CA199、CA153、CA125水平,并进行统计学分析。结果各组间血清TK1、CEA、AFP、CA199、CA153、CA125检测水平差异均有统计学意义(P均〈0.01)。对照组与恶性肿瘤组比较,各指标检测水平差异均有统计学意义(P均〈0.01),与良性增生组比较,各指标检测水平差异均无统计学意义(P均〉0.05),与癌前病变组比较,除TK1(P〈0.01)外,其余各指标检测水平差异均无统计学意义(P均〉0.05);恶性肿瘤组分别与良性增生组及癌前病变组比较,各指标检测水平差异均有统计学意义(P均〈0.01),良性增生组与癌前病变组比较,除TK1(P〈0.01)外,其余各指标检测水平差异均无统计学意义(P均〉0.05)。受试者工作特征曲线分析,TK1对于恶性肿瘤的诊断敏感度为93.1%,特异性为73.3%,曲线下面积为0.90;465例健康体检者中早期发现恶性肿瘤2例,均尚无临床症状及影像学改变。结论血清TK1检测对于恶性肿瘤的早期诊断具有重要诊断价值。 Objective To assess the earlier diagnostic value of thymidine kinase 1 (TK1) on malignant tumors. Methods 465 cases healthy check-up, 43 cases control, 39 cases benign hyperplasia, 37 cases malignant tumors and 34 cases precancerous lesions were collected. The levels of TK1 were detected by enhanced chemoluminescence dot blot assay,and the levels of serum tumor markers (CEA, AFP, CA199, CA153, CA125 ) were detected by particles chemiluminescence method and the results were analyzed statistically. Results There were statistical significance in the differences of TK1, CEA, AFP, CA199, CA153, CA125 levels among all the groups (Pall〈 0.01 ). The levels of all markers in malignant tumors group were all higher than in control group, and the differences all had statistical significance (Pall〈 0.01 ). There was no sta- tistical significance in the differences of all markers between benign hyperplasia group and control group (Pall〉 0.05) ; Contrast to control group, the levels of tumor markers in precancerous lesions group shown no statistical difference (Pall〉 0.05) except TK1 (P〈 0.01 ). The levels of all markers in malignant tumors group were all higher than in benign hyperplasia group and precancerous lesions group, and the differences all had statistical significance (Pall〈 0.01 ). Contrast to benign hyperplasia group, the levels of all markers in precancerous lesions group shown no statistical difference (Pall〉 0.05 ) except TK1 (P〈 0.01 ). Diagnostic sensitivity and speci- ficity of TK1 to malignant tumors were 93.1% and 73.3% by receiver operating characteristic curve and the area under curve was 0.90. Two cases of malignant tumors were found among 465 cases healthy check-up, without clinical symptoms and imaging radiculopathy. Conclusion Serum TK1 has significant early diagnostic value on malignant tumors.
作者 邢晓光
出处 《实用检验医师杂志》 2013年第2期92-95,共4页 Chinese Journal of Clinical Pathologist
基金 滨海新区卫生局科技扶持项目(2012BWKY015)
关键词 点印迹免疫酶化学发光法 胸苷激酶1 肿瘤标志物 恶性肿瘤 Enhanced chemolumineseence dot blot assay Thymidine kinase 1 Tumor marker Malignant tumor
  • 相关文献

参考文献11

二级参考文献58

  • 1Wu C, Yang R, Zhou J, et al. Production and characterization of a novel chicken IgY antibody raised against C terminal peptide from human thymidine kinasel[J]. J Immunol Met hods, 2003, 277(1-2) : 157-169.
  • 2Luo P,He E,Eriksson S, et al. Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker [J]. Eur J Cancer Prey,2009,18(3) :220-224.
  • 3Ohrvik A,Lindh M,Einarsson R, et al. Sensitive nonradiometric method for determining thymidine kinase 1 activity [J]. Clin Chem, 2004,50: 1597-1606.
  • 4Gasparri F, Wang N, Skog S, et al. Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan assays[J]. Eur J Cell Biol, 2009,88(12) :779-785.
  • 5He Q,Zhang P G,Zou L,et al. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation maker in human solid tumor than its activity [J]. Ontology Report,2007, 14(4) :1013-1019.
  • 6Chen Z, Zhou H, Li S, et al. Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours [J]. Anticaneer Res,2008, 28(6B) :3897-3907.
  • 7Zhang J,Jia Q, Zou S,et alTh. ymidine kinase l:a p roliferation marker for deter mining p rognosis and monit oring the surgical out come of p rimary bladder carcinoma patients [J]. Oncol Rep, 2006,15 (2) : 455-461.
  • 8Brockenbrough J S, Morihara J K, Hawes S E, et al. Thymidine kinase 1 and thymidine phosphorylase expression in non-small- cell lung carcinoma in relation to angiogenesis and proliferation [J]. J Histochem Cytochem, 2009,57(11) : 1087-1097.
  • 9Ulmert D,Cronin A M,Bjork T,et al.Prostate-specificantigen at or before age50as a predictor of advanced prostatecancer diagnosed up to25years later:a case-control study[J].BMC Med,2008,6(1):6-8.
  • 10Zhang J,Jia Q,Zou S,et al.Thymidine kinase1:aproliferation marker for determining prognosis and monitoringthe surgical outcome of primary bladder carcinoma patients[J].Oncol Rep,2006,15(2):455-461.

共引文献69

同被引文献12

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部